{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:11:51Z","timestamp":1791612711834,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Vasopressors and inotropes remain the cornerstone in treatment of acute myocardial infarction-related cardiogenic shock (AMI-CS). Milrinone and dobutamine are both commonly used, yet the optimal inotrope remains unclear. We aimed to identify factors associated with milrinone and dobutamine treatment and assess their effects on 30-day mortality in a large real-world cohort of AMI-CS patients. The Netherlands Heart Registration prospectively records data for percutaneous coronary intervention patients. Between 2017 and 2021, additional retrospective data on CS patients were collected by fourteen Dutch hospitals. Patients who were treated with either milrinone or dobutamine were selected; those treated with both were excluded. Missing data were imputed (30\u2009\u00d7) using multiple imputation, and propensity matched score analysis (PSM) was performed to evaluate the association between milrinone or dobutamine treatment and 30-day mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total, 739 patients were included (milrinone <jats:italic>n<\/jats:italic>\u2009=\u2009247, dobutamine <jats:italic>n<\/jats:italic>\u2009=\u2009492). Prior to matching, milrinone-treated patients exhibited more severely ill baseline and treatment characteristics, and higher 30-day mortality (50.6% vs. 41.5%, <jats:italic>p<\/jats:italic>\u2009=\u20090.018). After PSM, 198 patients remained in each group for analysis. Baseline characteristics were well balanced and 30-day mortality rates were similar (46.5% vs. 41.9%, <jats:italic>p<\/jats:italic>\u2009=\u20090.362).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In this real-world propensity-matched cohort of AMI-CS patients, no significant difference in 30-day mortality was observed between patients treated with milrinone and dobutamine. Importantly, milrinone patients were more severely ill at baseline, indicating that the choice of inotrope may be influenced by illness severity. This comprehensive study suggests that the selection of inotrope may continue to be guided by individual patient characteristics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical Abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s00392-025-02742-0","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:27:23Z","timestamp":1756895243000},"page":"1414-1426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Milrinone versus dobutamine in acute myocardial infarction-related cardiogenic shock; a propensity score matched analysis"],"prefix":"10.1007","volume":"114","author":[{"given":"Sanne","family":"ten Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margriet","family":"Bogerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elma J.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke J. C.","family":"Timmermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim K.","family":"Lagrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luuk C.","family":"Otterspoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P. J.","family":"Vlaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie E.","family":"Engstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8969-7929","authenticated-orcid":false,"given":"Jos\u00e9 P. S.","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the PCI Registration Committee of the Netherlands Heart Registration","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Meuwissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Grundeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Al Hashimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Teeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Magro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Diletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. J.","family":"Sorgdrager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E.","family":"Schotborgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J. R.","family":"Snijder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Polad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Scherptong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J. W.","family":"van\u2019\u2018t Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Spano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. G.","family":"van Houwelingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"McClelland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"van Ramshorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Amoroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Camaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. W.","family":"Danse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sjauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. K.","family":"Arkenbout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. T.","family":"Ruifrok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. O.","family":"Kraaijeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lipsic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hoebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"2742_CR1","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","volume":"136","author":"S van Diepen","year":"2017","unstructured":"van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG (2017) Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation 136:e232\u2013e268","journal-title":"Circulation"},{"key":"2742_CR2","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","volume":"40","author":"H Thiele","year":"2019","unstructured":"Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S (2019) Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J 40:2671\u20132683","journal-title":"Eur Heart J"},{"key":"2742_CR3","doi-asserted-by":"crossref","unstructured":"Karami M, Peters EJ, Lagrand WK, Houterman S, den Uil CA, Engstrom AE, Otterspoor LC, Ottevanger JP, Ferreira IA, Montero-Cabezas JM, Sjauw K, van Ramshorst J, Kraaijeveld AO, Verouden NJW, Lipsic E, Vlaar AP, Henriques JPS, On behalf of the Pci Registration Committee of the Netherlands Heart R, (2021) Outcome and predictors for mortality in patients with cardiogenic shock: a Dutch nationwide registry-based study of 75,407 Patients with acute coronary syndrome treated by PCI. J Clin Med 10","DOI":"10.1093\/ehjacc\/zuab020.207"},{"key":"2742_CR4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.7326\/0003-4819-149-9-200811040-00005","volume":"149","author":"RV Jeger","year":"2008","unstructured":"Jeger RV, Radovanovic D, Hunziker PR, Pfisterer ME, Stauffer JC, Erne P, Urban P, Investigators APR (2008) Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med 149:618\u2013626","journal-title":"Ann Intern Med"},{"key":"2742_CR5","first-page":"16","volume":"7","author":"KS Rathod","year":"2018","unstructured":"Rathod KS, Koganti S, Iqbal MB, Jain AK, Kalra SS, Astroulakis Z, Lim P, Rakhit R, Dalby MC, Lockie T, Malik IS, Knight CJ, Whitbread M, Mathur A, Redwood S, MacCarthy PA, Sirker A, O\u2019Mahony C, Wragg A, Jones DA (2018) Contemporary trends in cardiogenic shock: incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group. Eur Heart J Acute Cardiovasc Care 7:16\u201327","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"2742_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00392-017-1192-0","volume":"107","author":"T Backhaus","year":"2018","unstructured":"Backhaus T, Fach A, Schmucker J, Fiehn E, Garstka D, Stehmeier J, Hambrecht R, Wienbergen H (2018) Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry. Clin Res Cardiol 107:371\u2013379","journal-title":"Clin Res Cardiol"},{"key":"2742_CR7","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","volume":"377","author":"H Thiele","year":"2017","unstructured":"Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Savonitto S, Torremante P, Vrints C, Schneider S, Desch S, Zeymer U, Investigators C-S (2017) PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 377:2419\u20132432","journal-title":"N Engl J Med"},{"key":"2742_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2021.01.002","volume":"234","author":"H Thiele","year":"2021","unstructured":"Thiele H, Freund A, Gimenez MR, de Waha-Thiele S, Akin I, Poss J, Feistritzer HJ, Fuernau G, Graf T, Nef H, Hamm C, Bohm M, Lauten A, Schulze PC, Voigt I, Nordbeck P, Felix SB, Abel P, Baldus S, Laufs U, Lenk K, Landmesser U, Skurk C, Pieske B, Tschope C, Hennersdorf M, Wengenmayer T, Preusch M, Maier LS, Jung C, Kelm M, Clemmensen P, Westermann D, Seidler T, Schieffer B, Rassaf T, Mahabadi AA, Vasa-Nicotera M, Meincke F, Seyfarth M, Kersten A, Rottbauer W, Boekstegers P, Muellenbach R, Dengler T, Kadel C, Schempf B, Karagiannidis C, Hopf HB, Lehmann R, Bufe A, Baumanns S, Oner A, Linke A, Sedding D, Ferrari M, Bruch L, Goldmann B, John S, Mollmann H, Franz J, Lapp H, Lauten P, Noc M, Goslar T, Oerlecke I, Ouarrak T, Schneider S, Desch S, Zeymer U, Investigators E-S (2021) Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - design and rationale of the ECLS-SHOCK trial. Am Heart J 234:1\u201311","journal-title":"Am Heart J"},{"key":"2742_CR9","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ahj.2012.03.012","volume":"163","author":"H Thiele","year":"2012","unstructured":"Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, Hennersdorf M, Empen K, Fuernau G, Desch S, de Waha S, Eitel I, Hambrecht R, Bohm M, Kurowski V, Lauer B, Minden HH, Figulla HR, Braun-Dullaeus RC, Strasser RH, Rochor K, Maier SK, Mollmann H, Schneider S, Ebelt H, Werdan K, Zeymer U (2012) Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the intraaortic balloon pump in cardiogenic shock II (IABP-SHOCK II) trial. Am Heart J 163:938\u2013945","journal-title":"Am Heart J"},{"key":"2742_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJM199908263410901","volume":"341","author":"JS Hochman","year":"1999","unstructured":"Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341:625\u2013634","journal-title":"N Engl J Med"},{"key":"2742_CR11","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","volume":"390","author":"JE Moller","year":"2024","unstructured":"Moller JE, Engstrom T, Jensen LO, Eiskjaer H, Mangner N, Polzin A, Schulze PC, Skurk C, Nordbeck P, Clemmensen P, Panoulas V, Zimmer S, Schafer A, Werner N, Frydland M, Holmvang L, Kjaergaard J, Sorensen R, Lonborg J, Lindholm MG, Udesen NLJ, Junker A, Schmidt H, Terkelsen CJ, Christensen S, Christiansen EH, Linke A, Woitek FJ, Westenfeld R, Mobius-Winkler S, Wachtell K, Ravn HB, Lassen JF, Boesgaard S, Gerke O, Hassager C, DanGer Shock I (2024) Microaxial flow pump or standard care in infarct-related cardiogenic shock. N Engl J Med 390:1382\u20131393","journal-title":"N Engl J Med"},{"key":"2742_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","volume":"362","author":"D De Backer","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL, Investigators SI (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:779\u2013789","journal-title":"N Engl J Med"},{"key":"2742_CR13","doi-asserted-by":"crossref","unstructured":"Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, Quenot JP, Kimmoun A, Cariou A, Lassus J, Harjola VP, Meziani F, Louis G, Rossignol P, Duarte K, Girerd N, Mebazaa A, Vignon P, Collaborators, (2018) Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 72: 173\u2013182","DOI":"10.1016\/j.jacc.2018.04.051"},{"key":"2742_CR14","unstructured":"McDonagh TA (2021) 2021 ESC Guidelines for the diagnosis and"},{"key":"2742_CR15","unstructured":"treatment of acute and chronic heart failure. In: Editor (ed)^(eds) Book 2021 ESC guidelines for the diagnosis and"},{"key":"2742_CR16","unstructured":"treatment of acute and chronic heart failure. City, pp. 3599\u20133726"},{"key":"2742_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006191","volume":"12","author":"P Jain","year":"2019","unstructured":"Jain P, Shehab S, Muthiah K, Robson D, Granegger M, Drakos SG, Jansz P, Macdonald PS, Hayward CS (2019) Insights into myocardial oxygen consumption, energetics, and efficiency under left ventricular assist device support using noninvasive pressure-volume loops. Circ Heart Fail 12","journal-title":"Circ Heart Fail"},{"key":"2742_CR18","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1053\/j.jvca.2018.04.032","volume":"32","author":"AM Eskandr","year":"2018","unstructured":"Eskandr AM, Metwally AA, Abu Elkassem MS, Sadik SA, Elmiligy AE, Mourad M, Hussein L (2018) Dobutamine and nitroglycerin versus milrinone for perioperative management of pulmonary hypertension in mitral valve surgery. A randomized controlled study. J Cardiothorac Vasc Anesth 32:2540\u20132546","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2742_CR19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1056\/NEJMoa2026845","volume":"385","author":"R Mathew","year":"2021","unstructured":"Mathew R, Di Santo P, Jung RG, Marbach JA, Hutson J, Simard T, Ramirez FD, Harnett DT, Merdad A, Almufleh A, Weng W, Abdel-Razek O, Fernando SM, Kyeremanteng K, Bernick J, Wells GA, Chan V, Froeschl M, Labinaz M, Le May MR, Russo JJ, Hibbert B (2021) Milrinone as compared with dobutamine in the treatment of cardiogenic shock. N Engl J Med 385:516\u2013525","journal-title":"N Engl J Med"},{"key":"2742_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s12471-022-01672-0","volume":"30","author":"Timmermans MJC, Houterman S, Daeter ED, Danse PW, Li WW, Lipsic E, Roefs MM, van Veghel D, Registration PCIRCotNH, the Cardiothoracic Surgery Registration Committee of the Netherlands Heart R","year":"2022","unstructured":"Timmermans MJC, Houterman S, Daeter ED, Danse PW, Li WW, Lipsic E, Roefs MM, van Veghel D, Registration PCIRCotNH, the Cardiothoracic Surgery Registration Committee of the Netherlands Heart R (2022) Using real-world data to monitor and improve quality of care in coronary artery disease: results from the Netherlands Heart Registration. Neth Heart J 30:546\u2013556","journal-title":"Neth Heart J"},{"key":"2742_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12471-024-01877-5","volume":"32","author":"Derks L, Medendorp NM, Houterman S, Umans V, Maessen JG, van Veghel D, all Registration Committees of the Netherlands Heart R","year":"2024","unstructured":"Derks L, Medendorp NM, Houterman S, Umans V, Maessen JG, van Veghel D, all Registration Committees of the Netherlands Heart R (2024) Building a patient-centred nationwide integrated cardiac care registry: intermediate results from the Netherlands. Neth Heart J 32:228\u2013237","journal-title":"Neth Heart J"},{"key":"2742_CR22","doi-asserted-by":"crossref","unstructured":"Peters EJ, Berg ST, Bogerd M, Timmermans MJC, Kraaijeveld AO, Bunge JJH, Teeuwen K, Lipsic E, Sjauw KD, Geuns RMV, Dedic A, Dubois EA, Meuwissen M, Danse P, Verouden NJW, Bleeker G, Cabezas JMM, Ferreira IA, Engstrom AE, Lagrand WK, Otterspoor LC, Vlaar APJ, Henriques JPS, On behalf of the participating centers of the Pci Registration Committee of the Netherlands Heart R, (2023) Characteristics, treatment strategies and outcome in cardiogenic shock complicating acute myocardial infarction: a contemporary Dutch cohort. J Clin Med 12","DOI":"10.3390\/jcm12165221"},{"key":"2742_CR23","doi-asserted-by":"crossref","unstructured":"van Buuren S, Groothuis-Oudshoorn K (2011) mice: multivariate imputation by chained equations in R. In: Editor (ed)^(eds) Book mice: multivariate imputation by chained equations in R. City, pp. 1\u201367","DOI":"10.18637\/jss.v045.i03"},{"key":"2742_CR24","doi-asserted-by":"crossref","unstructured":"Peters EJ, Kunkel JB, Bogerd M, Ten Berg S, Timmermans MJC, Helgestad OKL, Ravn HB, Kraaijeveld AO, Otterspoor LC, Sjauw KD, Lipsic E, Engstrom AE, Vlaar APJ, Hassager C, Moller JE, Henriques JPS, (2025) Development and validation of a risk score in acute myocardial infarction related cardiogenic shock. Eur Heart J Acute Cardiovasc Care","DOI":"10.1093\/ehjacc\/zuaf043"},{"key":"2742_CR25","doi-asserted-by":"crossref","unstructured":"Pirracchio R, Parenica J, Resche Rigon M, Chevret S, Spinar J, Jarkovsky J, Zannad F, Alla F, Mebazaa A, network G, (2013) The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis. PLoS One 8: e71659","DOI":"10.1371\/journal.pone.0071659"},{"key":"2742_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021570","volume":"10","author":"RG Jung","year":"2021","unstructured":"Jung RG, Di Santo P, Mathew R, Abdel-Razek O, Parlow S, Simard T, Marbach JA, Gillmore T, Mao B, Bernick J, Theriault-Lauzier P, Fu A, Lau L, Motazedian P, Russo JJ, Labinaz M, Hibbert B (2021) Implications of myocardial infarction on management and outcome in cardiogenic shock. J Am Heart Assoc 10","journal-title":"J Am Heart Assoc"},{"key":"2742_CR27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1067\/mhj.2003.50","volume":"145","author":"JM Aranda Jr","year":"2003","unstructured":"Aranda JM Jr, Schofield RS, Pauly DF, Cleeton TS, Walker TC, Monroe VS Jr, Leach D, Lopez LM, Hill JA (2003) Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial. Am Heart J 145:324\u2013329","journal-title":"Am Heart J"},{"key":"2742_CR28","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/CIRCHEARTFAILURE.108.839076","volume":"2","author":"EZ Gorodeski","year":"2009","unstructured":"Gorodeski EZ, Chu EC, Reese JR, Shishehbor MH, Hsich E, Starling RC (2009) Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. Circ Heart Fail 2:320\u2013324","journal-title":"Circ Heart Fail"},{"key":"2742_CR29","volume":"5","author":"O Abdel-Razek","year":"2023","unstructured":"Abdel-Razek O, Di Santo P, Jung RG, Parlow S, Motazedian P, Prosperi-Porta G, Visintini S, Marbach JA, Ramirez FD, Simard T, Labinaz M, Mathew R, Hibbert B (2023) Efficacy of milrinone and dobutamine in cardiogenic shock: an updated systematic review and meta-analysis. Crit Care Explor 5","journal-title":"Crit Care Explor"},{"key":"2742_CR30","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1002\/ehf2.14379","volume":"10","author":"E Rodenas-Alesina","year":"2023","unstructured":"Rodenas-Alesina E, Luis Scolari F, Wang VN, Brahmbhatt DH, Mihajlovic V, Fung NL, Otsuki M, Billia F, Overgaard CB, Luk A (2023) Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure. ESC Heart Fail 10:2577\u20132587","journal-title":"ESC Heart Fail"},{"key":"2742_CR31","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/0002-9149(87)90616-3","volume":"60","author":"EJ Eichhorn","year":"1987","unstructured":"Eichhorn EJ, Konstam MA, Weiland DS, Roberts DJ, Martin TT, Stransky NB, Salem DN (1987) Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 60:1329\u20131333","journal-title":"Am J Cardiol"},{"key":"2742_CR32","doi-asserted-by":"crossref","unstructured":"Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A, European Milrinone Multicenter Trial G, (2001) Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 15: 306\u2013315","DOI":"10.1053\/jcan.2001.23274"},{"key":"2742_CR33","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/0002-9149(81)90087-4","volume":"48","author":"R Bendersky","year":"1981","unstructured":"Bendersky R, Chatterjee K, Parmley WW, Brundage BH, Ports TA (1981) Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics. Am J Cardiol 48:554\u2013558","journal-title":"Am J Cardiol"},{"key":"2742_CR34","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0735-1097(86)80231-5","volume":"7","author":"R Grose","year":"1986","unstructured":"Grose R, Strain J, Greenberg M, LeJemtel TH (1986) Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure. J Am Coll Cardiol 7:1107\u20131113","journal-title":"J Am Coll Cardiol"},{"key":"2742_CR35","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145:e895\u2013e1032","journal-title":"Circulation"},{"key":"2742_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100393","volume":"2","author":"P Di Santo","year":"2023","unstructured":"Di Santo P, Dehghan K, Mao B, Jung RG, Fadare D, Paydar J, Parlow S, Motazedian P, Prosperi-Porta G, Abdel-Razek O, Joseph J, Goh CY, Chung K, Mulloy A, Ramirez FD, Simard T, Hibbert B, Mathew R, Russo JJ (2023) Milrinone vs dobutamine for the management of cardiogenic shock: implications of renal function and injury. JACC Adv 2","journal-title":"JACC Adv"},{"key":"2742_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ahj.2023.04.010","volume":"262","author":"S Parlow","year":"2023","unstructured":"Parlow S, Santo PD, Sterling LH, Goodliffe L, Motazedian P, Prosperi-Porta G, Morgan B, Koopman Z, Jung RG, Lepage-Ratte MF, Robinson L, Feagan H, Simard T, Wells GA, Kyeremanteng K, Ainsworth C, Amin F, Marbach JA, Fernando SM, Labinaz M, Belley-Cote EP, Hibbert B, Mathew R (2023) Inotrope versus placebo therapy in cardiogenic shock: rationale and study design of the CAPITAL DOREMI2 trial. Am Heart J 262:83\u201389","journal-title":"Am Heart J"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02742-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02742-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02742-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T11:34:09Z","timestamp":1758713649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02742-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2742"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02742-0","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"17 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board Medical research Ethics Committees United (W19.270) and a waiver for informed consent was granted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}